Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin vs Intralesional Steroids in Oral Submucous Fibrosis
NCT06758739Phase 3Not yet recruiting
- Sponsor
- Services Institute of Medical Sciences
- Start
- Apr 2025
- Primary completion
- Sep 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in Oral submucous fibrosis (OSF), sponsored by Services Institute of Medical Sciences. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
curcumin
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT06758739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06758739.